Experience of [177Lu]Lu-PSMA-617-administration using totally implantable venous access port: simulated experiments and clinical SPECT analyses

  • Abstract
  • References
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

Experience of [177Lu]Lu-PSMA-617-administration using totally implantable venous access port: simulated experiments and clinical SPECT analyses

ReferencesShowing 10 of 11 papers
  • Cite Count Icon 3
  • 10.1097/rlu.0000000000004811
177Lu-PSMA Treatment Monitoring Through Serial Fast Whole-Body Tomoscintigraphies Recorded With a Latest-Generation CZT-Camera.
  • Aug 30, 2023
  • Clinical nuclear medicine
  • Caroline Boursier + 4 more

  • Open Access Icon
  • Cite Count Icon 1765
  • 10.1056/nejmoa2107322
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
  • Sep 16, 2021
  • New England Journal of Medicine
  • Oliver Sartor + 19 more

  • Open Access Icon
  • Cite Count Icon 112
  • 10.1016/j.ejso.2011.06.016
Totally implantable venous access port systems and risk factors for complications: A one-year prospective study in a cancer centre
  • Aug 9, 2011
  • European Journal of Surgical Oncology (EJSO)
  • F Narducci + 8 more

  • Open Access Icon
  • Cite Count Icon 637
  • 10.1148/ryai.230024
TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images.
  • Jul 5, 2023
  • Radiology: Artificial Intelligence
  • Jakob Wasserthal + 11 more

  • Cite Count Icon 190
  • 10.1016/s1470-2045(02)00905-1
Totally implantable venous-access ports: local problems and extravasation injury
  • Nov 1, 2002
  • The Lancet Oncology
  • Sidika Kurul + 2 more

  • Open Access Icon
  • Cite Count Icon 4
  • 10.1148/ryai.220292
Development and Evaluation of Deep Learning Models for Automated Estimation of Myelin Maturation Using Pediatric Brain MRI Scans.
  • Jul 26, 2023
  • Radiology: Artificial Intelligence
  • Tugba Akinci D’Antonoli + 6 more

  • Open Access Icon
  • Cite Count Icon 291
  • 10.1023/a:1008392423469
Totally implantable central venous access ports for long-term chemotherapy A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days
  • Jul 1, 1998
  • Annals of Oncology
  • R Biffi + 7 more

  • Open Access Icon
  • Cite Count Icon 159
  • 10.1093/annonc/mds294
Management of chemotherapy extravasation: ESMO–EONS Clinical Practice Guidelines
  • Oct 1, 2012
  • Annals of Oncology
  • J.A Pérez Fidalgo + 5 more

  • Cite Count Icon 789
  • 10.1016/s0140-6736(21)00237-3
177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
  • Feb 1, 2021
  • The Lancet
  • Thean Hsiang Tan + 33 more

  • Cite Count Icon 91
  • 10.3928/1542-8877-19930101-11
Allograft Rejection After Penetrating Keratoplasty for Keratoconus
  • Jan 1, 1993
  • Ophthalmic Surgery, Lasers and Imaging Retina
  • Louis J Girard + 5 more

More from: EJNMMI Research
  • New
  • Addendum
  • 10.1186/s13550-025-01331-6
Correction: 89Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs
  • Nov 4, 2025
  • EJNMMI Research
  • Kevin Wyszatko + 10 more

  • Research Article
  • 10.1186/s13550-025-01322-7
Bimodality imaging as a companion to evaluate antitumour efficacy of TH-302 in experimental chondrosarcoma
  • Oct 27, 2025
  • EJNMMI Research
  • Roxane Autissier + 10 more

  • Research Article
  • 10.1186/s13550-025-01299-3
In vivo gastrin releasing peptide receptor expression in SDH deficient wild-type gastrointestinal stromal tumours (GIST): potential for theranostic applications
  • Oct 21, 2025
  • EJNMMI Research
  • David G E Hulse + 12 more

  • Research Article
  • 10.1186/s13550-025-01321-8
A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma
  • Oct 15, 2025
  • EJNMMI Research
  • Hong Chen + 8 more

  • Research Article
  • 10.1186/s13550-025-01326-3
Quantitative terbium-161 SPECT/CT imaging: demonstrating the feasibility of image-based dosimetry and highlighting pitfalls
  • Oct 13, 2025
  • EJNMMI Research
  • Frida Westerbergh + 5 more

  • Research Article
  • 10.1186/s13550-025-01317-4
Staging lung cancer: total-body PET/CT or whole-body PET/CT?
  • Oct 8, 2025
  • EJNMMI Research
  • Xiaoxiang Zhang + 9 more

  • Research Article
  • 10.1186/s13550-025-01327-2
Hepatobiliary PET with [68Ga]Ga-BP-IDA – preclinical evaluation and its translational potential for liver function monitoring
  • Oct 2, 2025
  • EJNMMI Research
  • Julia Greiser + 14 more

  • Research Article
  • 10.1186/s13550-025-01328-1
The impact of short-term non-steroidal androgen antagonist therapy on PSMA expression and tumor cellularity studied with dynamic [68Ga]Ga-PSMA-11 PET/MR in hormone-sensitive prostate cancer patients, a preliminary longitudinal prospective study
  • Oct 2, 2025
  • EJNMMI Research
  • Alejandro Sanchez-Crespo + 6 more

  • Research Article
  • 10.1186/s13550-025-01316-5
Experience of [177Lu]Lu-PSMA-617-administration using totally implantable venous access port: simulated experiments and clinical SPECT analyses
  • Sep 26, 2025
  • EJNMMI Research
  • Adèle Lombard + 12 more

  • Research Article
  • 10.1186/s13550-025-01315-6
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism
  • Sep 26, 2025
  • EJNMMI Research
  • Marc C Huisman + 18 more

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.

Search IconWhat is the difference between bacteria and viruses?
Open In New Tab Icon
Search IconWhat is the function of the immune system?
Open In New Tab Icon
Search IconCan diabetes be passed down from one generation to the next?
Open In New Tab Icon